Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Stephanie Hanson Guseh, M.D.

Concepts (110)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Prenatal Diagnosis5202312641.240 Why?
Fetal Heart320242810.860 Why?
Fetal Therapies220241010.850 Why?
Genetic Diseases, Inborn320236010.770 Why?
Aneuploidy320235510.700 Why?
Fetal Diseases320249110.700 Why?
Chromosome Disorders120214990.610 Why?
Genetic Counseling120216240.580 Why?
Prenatal Care3202011290.520 Why?
Complement Membrane Attack Complex120141050.480 Why?
Emotional Intelligence120151350.470 Why?
Hypoplastic Left Heart Syndrome120205940.470 Why?
Aortic Valve Stenosis3202220650.450 Why?
Unnecessary Procedures120154130.400 Why?
Appointments and Schedules120154420.380 Why?
Pregnancy142024297490.360 Why?
Heart Defects, Congenital2202446730.360 Why?
Gynecology120155280.340 Why?
Clinical Clerkship120155630.340 Why?
Down Syndrome120178920.320 Why?
Obstetrics120156670.320 Why?
Delivery, Obstetric120159320.310 Why?
Carcinoma, Transitional Cell220148000.300 Why?
Cesarean Section1201513850.280 Why?
Gestational Age1201535650.270 Why?
Pre-Eclampsia1201412290.250 Why?
Adaptation, Psychological1201526280.240 Why?
Ovarian Neoplasms4201448780.240 Why?
Ultrasonography, Prenatal2202417450.230 Why?
Delivery Rooms12023380.220 Why?
Students, Medical1201519270.200 Why?
Vein of Galen Malformations12023580.200 Why?
Cerebral Veins120231570.200 Why?
Semen120233460.180 Why?
False Negative Reactions120195730.160 Why?
False Positive Reactions120199560.140 Why?
Female2120243912700.140 Why?
Fetal Blood1202313430.130 Why?
Pregnancy Proteins120142220.110 Why?
Genetic Testing2202335310.110 Why?
Embolization, Therapeutic1202314130.110 Why?
Organizational Policy120154290.110 Why?
Fibroblast Growth Factor 2120145900.100 Why?
Organoplatinum Compounds120144100.100 Why?
Stem Cell Transplantation1202015990.100 Why?
Humans2320247606210.100 Why?
Vascular Endothelial Growth Factor Receptor-1120145580.090 Why?
Retrospective Studies72022803720.090 Why?
Fallopian Tube Neoplasms120133280.090 Why?
Leiomyosarcoma120134240.080 Why?
Neoplasms, Glandular and Epithelial120134870.080 Why?
Survival Rate42014128080.070 Why?
High-Throughput Nucleotide Sequencing1201936160.070 Why?
Neoplasm Staging42014111520.070 Why?
Carcinoma, Lobular120114890.070 Why?
Disease-Free Survival2201468280.070 Why?
Case-Control Studies22014220530.070 Why?
Peritoneal Neoplasms120137070.070 Why?
Neoplasm, Residual1201110070.070 Why?
Adult820232199940.060 Why?
Mastectomy, Segmental120119720.060 Why?
DNA1201972330.060 Why?
Fetus2202318590.060 Why?
Neoadjuvant Therapy2201428210.060 Why?
Boston1201792800.060 Why?
Uterine Neoplasms1201314390.060 Why?
Neoplasm Recurrence, Local2201392760.060 Why?
Carcinoma, Intraductal, Noninfiltrating120119360.060 Why?
Carcinoma, Ductal, Breast1201110960.060 Why?
Vascular Endothelial Growth Factor A1201434840.060 Why?
Angiogenesis Inhibitors1201320490.050 Why?
Kaplan-Meier Estimate1201465440.050 Why?
Health Policy1201526770.050 Why?
Nuchal Translucency Measurement12023590.050 Why?
Massachusetts1201588030.050 Why?
Comorbidity12017105510.050 Why?
Pilot Projects1201585550.050 Why?
Follow-Up Studies42014392610.040 Why?
Logistic Models12014133140.040 Why?
Drug Resistance, Neoplasm1201452530.040 Why?
Heart Failure12023118470.040 Why?
Patient Readmission1201333230.040 Why?
Probability1202324750.040 Why?
Prospective Studies12021543030.030 Why?
Ultrasonography, Interventional1202315020.030 Why?
Infant, Newborn22023261810.030 Why?
Male320233597440.030 Why?
Hemodynamics1202241740.020 Why?
Adenocarcinoma, Clear Cell120132170.020 Why?
Obesity12014129220.020 Why?
CA-125 Antigen120132790.020 Why?
Ultrasonography1202359610.020 Why?
Adenocarcinoma, Mucinous120135170.020 Why?
Middle Aged520142203520.020 Why?
Cystadenocarcinoma, Serous120134790.020 Why?
Prognosis32013296580.020 Why?
Treatment Outcome22022650170.020 Why?
Lymphatic Metastasis1201329430.020 Why?
Chemotherapy, Adjuvant1201435290.020 Why?
Endometrial Neoplasms1201313570.010 Why?
Aged, 80 and over32014589950.010 Why?
Breast Neoplasms12011210250.010 Why?
Combined Modality Therapy1201385520.010 Why?
Reoperation1201142910.010 Why?
Aged420141691520.010 Why?
Length of Stay1201364790.010 Why?
Liver Neoplasms1201343190.010 Why?
Body Mass Index12014129140.010 Why?
Animals120201679630.000 Why?
Risk Factors12013743590.000 Why?
Guseh's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (110)
Explore
_
Co-Authors (43)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.